Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril

Journal of the American College of Cardiology

Volumn 24, Issue 3, 1994, Pages 583-591

  Rouleau, Jean Lucien ^a   Packer, Milton ^b   Moyé, Lemuel ^c   de Champlain, Jacques ^d   Bichet, Daniel ^d   Klein, Marc ^d   Rouleau, Jacques R ^e   Sussex, Bruce ^f   Arnold, J Malcolm ^g   Sestier, François ^h   Parker, John O ⁱ   McEwan, Patricia ^j   Bernstein, Victoria ^k   Cuddy, T Edward ^l   Lamas, Gervasio ^m   Gottlieb, Stephen S ⁿ   McCans, John ^o   Nadeau, Claude ^p   Delage, François ^q   Wun, Chuan Chuan C ^c   Pfeffer, Marc A ^r   more..

^a MONTREAL HEART INSTITUTE   (Canada)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

^h NOTRE DAME HOSPITAL   (Canada)

ⁱ KINGSTON GENERAL HOSPITAL   (Canada)

^j WELLESLEY HOSPITAL   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m MOUNT SINAI MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^o MCGILL UNIVERSITY   (Canada)

^p LAVAL UNIVERSITY   (Canada)

^q Hotel Dieu de Levis Hospital   (Canada)

^r BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

AGED; ALDOSTERONE; ANALYSIS OF VARIANCE; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; CANADA; CAPTOPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENIN;

EID: 0028017360     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)90001-9     Document Type: Article

References (30)

1. Activation of neurohumoral systems following acute myocardial infarction
2. Activation of neurohumoral systems in postinfarction left ventricular dysfunction
3. The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction following myocardial infarction
4. Beta blockade during and after myocardial infarction: an overview of the randomized trials
5. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity
6. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity
7. Plasma atrial natriuretic peptide is unstable under most storage conditions
8. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms
9. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease
10. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
11. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure
12. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study
13. Angiotensin II and left ventricular growth in newborn pig heart
14. Plasma renin activity and ischemic heart disease
15. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
16. Effect of nitroglycerin and dipyridamole on regional coronary resistance
17. Polypeptide growth factors and atherosclerosis
18. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the reninangiotensin system and fibrinolytic function
19. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
20. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat
21. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure
22. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction
23. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
24. Atrial natriuretic hormone: a regulator of blood volume and volume homeostasis
25. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
26. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction results of the Studies of Left Ventricular Dysfunction (SOLVD) registry
27. 2 vasopressinergic receptors
28. Vascular role of vasopressin in the presence and absence of influence from angiotensin II or α-adrenergic system
29. Vasopression stimulation of mouse 3T3 cell growth
30. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II